Stock XCUR EXICURE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Exicure, Inc.

Equities

XCUR

US30205M2008

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
0.34 USD +4.15% Intraday chart for Exicure, Inc. +2.97% -41.41%
06-17 Exicure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06-17 Earnings Flash (XCUR) EXICURE Reports Q1 Revenue $500,000 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
EXICURE, INC. Stock Exicure, Inc.
 2.94M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 114B
ARGENX SE Stock argenx SE
 23.61B -
BIONTECH SE Stock BioNTech SE
 20.43B -
GENMAB A/S Stock Genmab A/S
 16.55B
  1. Stock Market
  2. Equities
  3. XCUR Stock
  4. Charts Exicure, Inc.
  5. Sector Chart